# CVE-2024-6181: LabVantage LIMS cross site scripting

> Remote attackers can execute arbitrary scripts via manipulated height/width parameters in LabVantage LIMS, potentially compromising user sessions.

- **Severity:** Medium 5.3 (`CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Over the internet
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 20 Jun 2024
- **Updated:** 1 Aug 2024
- **Also known as:** GHSA-vcpc-x3pw-9whm

## What is CVE-2024-6181?

CVE-2024-6181 is a medium-severity cross-site scripting vulnerability in LabVantage LIMS, published on 20 Jun 2024. Any signed-in user can exploit it over the network, with no action from the victim.

### Official description

A vulnerability was found in LabVantage LIMS 2017. It has been declared as problematic. This vulnerability affects unknown code of the file /labvantage/rc?command=file&file=WEB-CORE/elements/files/filesembedded.jsp&size=32. The manipulation of the argument height/width leads to cross site scripting. The attack can be initiated remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-269152. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Weakness: CWE-79 (Improper Neutralization of Input During Web Page Generation)

## Which versions are affected by CVE-2024-6181?

It affects 1 product.


Products: Labvantage Labvantage Lims.

## How do I fix CVE-2024-6181?

No fix has been published for CVE-2024-6181 yet. Limit exposure of the affected software until one is available.

## Is CVE-2024-6181 being exploited?

There is no known exploitation of CVE-2024-6181 in the wild and no public exploit code.

## Other vulnerabilities in LabVantage LIMS

- [CVE-2024-6182](https://insights.sbomify.com/CVE-2024-6182/): LabVantage LIMS cross site scripting (medium 5.3)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2024-6181 and fix it if it is affected.

What it is: CVE-2024-6181 is a medium-severity cross-site scripting vulnerability in LabVantage LIMS, published on 20 Jun 2024. Any signed-in user can exploit it over the network, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2024-6181 in the wild and no public exploit code.

Affected product: LabVantage LIMS. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2024-6181/ (Markdown: https://insights.sbomify.com/CVE-2024-6181/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2024-6181
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2024-6181
- OSV: https://osv.dev/vulnerability/CVE-2024-6181

---
From sbomify Insights: https://insights.sbomify.com/CVE-2024-6181/
Summaries are generated and may contain mistakes; the official description above is the record.